MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA

Coxsackievirus B3 (CVB3) is known to cause acute myocarditis and pancreatitis in humans. We investigated the microRNAs (miRNAs) that can potentially govern the viral life cycle by binding to the untranslated regions (UTRs) of CVB3 RNA. MicroRNA-22-3p was short-listed, as its potential binding site overlapped with the region crucial for recruiting internal ribosome entry site trans-acting factors (ITAFs) and ribosomes. We demonstrate that miR-22-3p binds CVB3 5' UTR, hinders recruitment of key ITAFs on viral mRNA, disrupts the spatial structure required for ribosome recruitment, and ultimately blocks translation. Likewise, cells lacking miR-22-3p exhibited heightened CVB3 infection compared to wild type, confirming its role in controlling infection. Interestingly, miR-22-3p level was found to be increased at 4 hours post-infection, potentially due to the accumulation of viral 2A protease in the early phase of infection. 2Apro enhances the miR-22-3p level to dislodge the ITAFs from the SD-like sequence, rendering the viral RNA accessible for binding of replication factors to switch to replication. Furthermore, one of the cellular targets of miR-22-3p, protocadherin-1 (PCDH1), was significantly downregulated during CVB3 infection. Partial silencing of PCDH1 reduced viral replication, demonstrating its proviral role. Interestingly, upon CVB3 infection in mice, miR-22-3p level was found to be downregulated only in the small intestine, the primary target organ, indicating its possible role in influencing tissue tropism. It appears miR-22-3p plays a dual role during infection by binding viral RNA to aid its life cycle as a viral strategy and by targeting a proviral protein to restrict viral replication as a host response.IMPORTANCECVB3 infection is associated with the development of end-stage heart diseases. Lack of effective anti-viral treatments and vaccines for CVB3 necessitates comprehensive understanding of the molecular players during CVB3 infection. miRNAs have emerged as promising targets for anti-viral strategies. Here, we demonstrate that miR-22-3p binds to 5' UTR and inhibits viral RNA translation at the later stage of infection to promote viral RNA replication. Conversely, as host response, it targets PCDH1, a proviral factor, to discourage viral propagation. miR-22-3p also influences CVB3 tissue tropism. Deciphering the multifaced role of miR-22-3p during CVB3 infection unravels the necessary molecular insights, which can be exploited for novel intervening strategies to curb infection and restrict viral pathogenesis.

Medienart:	E-Artikel

Erscheinungsjahr:	2024
Erschienen:	2024

Enthalten in:	Zur Gesamtaufnahme - volume:98
Enthalten in:	Journal of virology - 98(2024), 2 vom: 20. Feb., Seite e0150423

Sprache:	Englisch

Beteiligte Personen:	Rani, Priya [VerfasserIn] George, Biju [VerfasserIn] V, Sabarishree [VerfasserIn] Biswas, Somarghya [VerfasserIn] V, Madhurya [VerfasserIn] Pal, Apala [VerfasserIn] Rajmani, Raju S [VerfasserIn] Das, Saumitra [VerfasserIn]

Links:	Volltext

Themen:	5' Untranslated Regions Antiviral Agents Coxsackievirus B3 Cysteine Endopeptidases EC 3.4.22.- EC 3.4.22.29 IRES-mediated translation Journal Article MIRN22 microRNA, human MicroRNAs Mirn22 microRNA, mouse PCDH1 protein, human Pcdh1 protein, mouse Picornain 2A, Picornavirus Protocadherins RNA, Viral

Anmerkungen:	Date Completed 21.02.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE

doi:	10.1128/jvi.01504-23

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	NLM367794586